Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • INSM vs GSK✓SelectedUSD · GSKINSM vs GSK performance historyLatest closeAs of+1.42%11/16
Stock and ETF performance explorer

INSM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+304.9%
GSK return
+47.4%
Excess return
+257.5%
Maximum drawdown
-56.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.4%-0.1%+1.5%+1.4%
7D+5.8%-1.3%+7.2%+6.2%
30D+27.6%+2.7%+24.9%+26.7%
3M-0.7%+2.7%-3.4%-1.4%
6M+12.6%+3.3%+9.3%+11.7%
YTD-29.4%+6.5%-35.9%-30.3%
1Y-36.4%+10.7%-47.1%-37.7%
3Y+402.8%+64.4%+338.4%+329.5%
All+304.9%+47.4%+257.5%+234.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling